What is iBio, Inc. Common Stock (IBIO) stock price today?

iBio, Inc. Common Stock (IBIO) currently trades at $1.59 per share. The stock has a market capitalization of $57.47M and a P/E ratio of —x.

Is IBIO stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, iBio, Inc. Common Stock has a Smart Value Score of 29/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is iBio, Inc. Common Stock's revenue and earnings?

iBio, Inc. Common Stock has trailing twelve-month (TTM) revenue of $300000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-1.00.

IBIO

iBio, Inc. Common Stock

NASDAQ: IBIO · HEALTHCARE · BIOTECHNOLOGY

$1.59

-5.92% today

Updated 2026-05-01

Market cap

$57.47M

P/E ratio

—

P/S ratio

191.56x

EPS (TTM)

$-1.00

Dividend yield

—

52W range

$1 – $4

Volume

1.0M

Market cap

$57.47M

P/E ratio

—

P/S ratio

191.56x

EPS (TTM)

$-1.00

Dividend yield

—

52W range

$1 – $4

Volume

1.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.0

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →205 stocks currently score above 75

Price targets

Analyst target

$5.37

+237.74%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 14.30% QoQ

Risks

- Thin margins at 0.00%

- Negative free cash flow $-5.76M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$1.88M	$50000.00	$225000.00	$400000.00	$300000.00
Net income	$-50.39M	$-29.31M	$-24.91M	$-18.38M	$-8.99M
EPS	—	—	—	—	$-1.00
Free cash flow	$-45.13M	$-36.17M	$-18.76M	$-15.32M	$-5.76M
Profit margin	-2,674.68%	-58,622.00%	-11,069.78%	-4,594.25%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
IBIO	$57.47M	29	4.0	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-41.61%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-26.29%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.35%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

iBio, Inc. Common Stock trades at $1.59. Our Smart Value Score of 29/100 indicates the stock is weak. TTM revenue stands at $300000.00.

Frequently asked questions

What is iBio, Inc. Common Stock's stock price?

iBio, Inc. Common Stock (IBIO) trades at $1.59.

Is iBio, Inc. Common Stock overvalued?

Smart Value Score 29/100 (Grade F, Strong Sell).

What is the price target of iBio, Inc. Common Stock (IBIO)?

The analyst target price is $5.37, representing +237.7% upside from the current price of $1.59.

What is iBio, Inc. Common Stock's revenue?

TTM revenue is $300000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio191.56x

ROE-70.20%

Beta1.36

50D MA$2.19

200D MA$1.56

Shares out0.04B

Float0.03B

Short ratio—

Avg volume1.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

IBIO vs LLY →IBIO vs JNJ →IBIO vs ABBV →Stock screener →